Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 9
1966 7
1967 13
1968 16
1969 14
1970 14
1971 14
1972 21
1973 22
1974 29
1975 57
1976 45
1977 45
1978 54
1979 59
1980 53
1981 58
1982 65
1983 88
1984 52
1985 68
1986 61
1987 75
1988 72
1989 57
1990 85
1991 72
1992 81
1993 81
1994 88
1995 104
1996 97
1997 96
1998 66
1999 72
2000 63
2001 59
2002 54
2003 54
2004 65
2005 61
2006 50
2007 67
2008 60
2009 47
2010 58
2011 48
2012 52
2013 59
2014 50
2015 54
2016 44
2017 42
2018 32
2019 49
2020 40
2021 35
2022 30
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

2,954 results
Results by year
Filters applied: . Clear all
Page 1
Indomethacin sustained-release?
Green JA. Green JA. Drug Intell Clin Pharm. 1984 Dec;18(12):1004-7. doi: 10.1177/106002808401801222. Drug Intell Clin Pharm. 1984. PMID: 6391883 Review.
When neither of these conditions is satisfied, then a sustained-release preparation may offer no advantages over the conventional formulation. The literature on indomethacin was examined with respect to the above conditions and it was concluded that its marketing as a sust …
When neither of these conditions is satisfied, then a sustained-release preparation may offer no advantages over the conventional formulatio …
Rectal indometacin to prevent pancreatitis after extracorporeal shock wave lithotripsy (RIPEP): a single-centre, double-blind, randomised, placebo-controlled trial.
Qian YY, Ru N, Chen H, Zou WB, Wu H, Pan J, Li B, Xin L, Guo JY, Tang XY, Hu LH, Jin ZD, Wang D, Du YQ, Wang LW, Li ZS, Liao Z. Qian YY, et al. Lancet Gastroenterol Hepatol. 2022 Mar;7(3):238-244. doi: 10.1016/S2468-1253(21)00434-9. Epub 2022 Jan 25. Lancet Gastroenterol Hepatol. 2022. PMID: 35085482 Clinical Trial.
Post-ESWL pancreatitis occurred in 60 (9%) patients in the rectal indometacin group and 84 (12%) patients in the placebo group (relative risk 0.71, 95% CI 0.52-0.98; p=0.042). Transient adverse events occurred in 235 (34%) patients in the rectal indometacin group an …
Post-ESWL pancreatitis occurred in 60 (9%) patients in the rectal indometacin group and 84 (12%) patients in the placebo group (relat …
Controlled-release indomethacin and sustained-release diclofenac sodium in the treatment of rheumatoid arthritis: a comparative controlled clinical trial.
Crowley B, Hamill JJ, Lyndon S, McKellican JF, Williams P, Miller AJ. Crowley B, et al. Curr Med Res Opin. 1990;12(3):143-50. doi: 10.1185/03007999009111495. Curr Med Res Opin. 1990. PMID: 2272188 Clinical Trial.
The efficacy and tolerability of a new, controlled-release indomethacin (75 mg) tablet was compared to that of a sustained-release diclofenac sodium (100 mg) tablet in 84 patients with rheumatoid arthritis. ...It was concluded that controlled-release indomethacin ta …
The efficacy and tolerability of a new, controlled-release indomethacin (75 mg) tablet was compared to that of a sustained-release di …
A clinical and pharmacokinetic study of indomethacin in standard and slow release formulations.
Adams KR, Halliday LD, Sibeon RG, Baber N, Littler T, Orme ML. Adams KR, et al. Br J Clin Pharmacol. 1982 Aug;14(2):286-9. doi: 10.1111/j.1365-2125.1982.tb01977.x. Br J Clin Pharmacol. 1982. PMID: 7104182 Free PMC article. Clinical Trial.
Fifteen patients with rheumatoid arthritis received indomethacin in three treatment schedules; indomethacin retard 75 mg twice daily; indomethacin capsules 50 mg three times daily; and indomethacin 100 mg suppository at night with 50 mg by mouth each m …
Fifteen patients with rheumatoid arthritis received indomethacin in three treatment schedules; indomethacin retard 75 mg twice …
Pharmacokinetics of indomethacin.
Alván G, Orme M, Bertilsson L, Ekstrand R, Palmér L. Alván G, et al. Clin Pharmacol Ther. 1975 Sep;18(3):364-73. doi: 10.1002/cpt1975183364. Clin Pharmacol Ther. 1975. PMID: 1100305 Clinical Trial.
Plasma concentrations of indomethacin have been studied in 5 healthy volunteers after single and multiple doses (25 mg intravenously [iv], 25, 50, and 100 mg orally, 100 mg rectally, and 25 mg three times daily [tid]. In 8 other normal subjects and in 5 patients a 50-mg or …
Plasma concentrations of indomethacin have been studied in 5 healthy volunteers after single and multiple doses (25 mg intravenously …
Naproxen and indomethacin in the treatment of primary dysmenorrhea.
Kajanoja P, Vesanto T. Kajanoja P, et al. Acta Obstet Gynecol Scand Suppl. 1979;87:87-9. doi: 10.3109/00016347909157797. Acta Obstet Gynecol Scand Suppl. 1979. PMID: 380254 Clinical Trial.
The efficacy of naproxen and indomethacin in the treatment of dysmenorrhea was compared in a double-blind, cross-over study. ...Gastrointestinal side-effects occurred in 5 and 7 patients during naproxen and indomethacin treatment respectively. Central nervous system …
The efficacy of naproxen and indomethacin in the treatment of dysmenorrhea was compared in a double-blind, cross-over study. ...Gastr …
Indomethacin in rheumatoid arthritis: clinical effects, pharmacokinetics, and platelet studies in responders and nonresponders.
Baber N, Halliday LD, van den Heuvel WJ, Walker RW, Sibeon R, Keenan JP, Littler T, Orme ML. Baber N, et al. Ann Rheum Dis. 1979 Apr;38(2):128-36. doi: 10.1136/ard.38.2.128. Ann Rheum Dis. 1979. PMID: 375848 Free PMC article. Clinical Trial.
Twenty patients with definite or classical rheumatoid arthritis entered and completed a sequential study of placebo for 1 week, oral indomethacin 25 mg 3 times a day for 3 weeks, and oral indomethacin 25 mg 3 times a day plus 100 mg indomethacin suppository a …
Twenty patients with definite or classical rheumatoid arthritis entered and completed a sequential study of placebo for 1 week, oral indo …
A long-term double-blind clinical trial of ibuprofen and indomethacin in rheumatoid arthritis.
Royer GL, Moxley TE, Hearron MS, Miyara A, Shenker BM. Royer GL, et al. J Int Med Res. 1975;3(3):158-71. doi: 10.1177/030006057500300304. J Int Med Res. 1975. PMID: 162672 Clinical Trial.
Two-hundred and eighteen individuals with rheumatoid arthritis were randomly assigned to six months treatment with ibuprofen (900-1800 mg/day) or indomethacin (75-150 mg/day). The drugs were equally effective in the treatment of rheumatoid arthritis while the incidence of …
Two-hundred and eighteen individuals with rheumatoid arthritis were randomly assigned to six months treatment with ibuprofen (900-1800 mg/da …
A comparative clinical trial of fenbufen and indomethacin in patients with rheumatoid arthritis.
Vergara-Castro JM, Arias LF, Greenberg BP. Vergara-Castro JM, et al. J Int Med Res. 1976;4(6):418-26. doi: 10.1177/030006057600400607. J Int Med Res. 1976. PMID: 800381 Clinical Trial.
A 12-week double-blind crossover trial compared fenbufen and indomethacin in 40 patients with rheumatoid arthritis. Fenbufen (600-800 mg/day) was significantly superior to indomethacin (75-100 mg/day) in improving the physical measurements of rheumatoid arthritis ac …
A 12-week double-blind crossover trial compared fenbufen and indomethacin in 40 patients with rheumatoid arthritis. Fenbufen (600-800 …
2,954 results